Our Programs

Who We Are

We are a diverse team of healthcare professionals who engage in groundbreaking research and collaborate with families to offer first-rate care to sick newborns.

Clinical Care

We deliver inclusive, family-centered care and offer specialized services in perinatal-neonatal medicine. 


We train neonatologists and developmental biologists to be leaders in their field.


We perform transdisciplinary research that promotes change, improving outcomes for mothers and babies.

In Brief | Division News


At the recent Stanford Health++ Hackathon on Oct. 21 and 22, Neonatal-Perinatal Medicine Fellow Anoop Rao, MD, MS, mentored three teams that devised designs to improve neonatal care. Two teams will advance to the finals. Designs included a parent-friendly interface that displays real-time positioning of an endotracheal tube, a scalable, web-based platform to help with patient referral to regional centers in low- and middle-income countries, and a 3D-printed device that stabilizes a baby's hand to enable easier arterial catheterization. 

DR. ANCA PASCA IS NAMED TO 2017 LIST OF STAT WUNDKERKINDS: STAT News honors the brighest young minds in life science for their work in academic, industry, and the clinic. Neonatal-Perinatal Medicine Fellow, Anca Pasca, MD, is one of two Stanford scientists to be chosen this year. Dr. Pasca creates models of infant brains in the laboratory to investigate neurodevelopmental problems associated with preterm birth. She is specifically interested in studying how insufficient oxygen impacts the developing brain and how to prevent brain damage.

DR. JOCHEN PROFIT AWARDED LECTURESHIP BY BETH ISRAEL DEACONESS MEDICAL CENTERJochen Profit, MD, MPH, is this year's recipient of BIDMC Department of Neonatology's Marie McCormick Lectureship in Health Services Research and Epidemiology. 

Publication Spotlight

DR. HENRY LEE INVESTIGATES SHORT-TERM COSTS ASSOCIATED WITH PREECLAMPSIA: In its Sept. 2017 issue, the American Journal of Obstetrics & Gynecology highlighted a paper assessing the short-term costs associated with preeclampsia to the United States health care system; Henry C. Lee, MD, MS, is a co-author. Preeclampsia is among the top six leading causes of maternal mortality and morbidity and adverse infant outcomes. While it affects more women today as average maternal age and obesity increase, little is known about how preeclampsia contributes to maternal and neonatal health cost burdens. Researchers employed a novel cost algorithm to assess spending related to this condition. Using administrative claims and population-based data sets from 2012, investigators showed that the total cost burden of preeclampsia in the first 12 months after birth was $1.03 billion for mothers and $1.15 billion for infants. The majority was spent on mothers and their infants who were born at lower gestational ages. An editorial published in the same AJOG issue evaluates the study and stresses the importance of finding ways to better treat preeclampsia.